2020
DOI: 10.1002/slct.202001580
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, Characterization, and Antiproliferative Activity Studies of Novel Benzimidazole‐Imidazopyridine Hybrids as DNA Groove Binders

Abstract: A novel benzimidazole‐imidazo[1,2‐a]pyridine hybrid; 2‐(imidazo[1,2‐a]pyridine‐8‐yl)benzimidazole and its symmetrical bis‐ derivative 2,2′‐bis‐(imidazo[1,2‐a]pyridine‐8‐yl)‐1H,1H′‐[5,5′]‐bisbenzimidazole were synthesized and characterized. It was found that these two compounds have a strong DNA groove binding and peroxide mediated DNA‐cleavage properties. Furthermore, these molecules were screened against three different human cell lines namely HepG2, DLD‐1 and MDA‐MB‐231, and these compounds were found to hav… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 83 publications
0
5
0
Order By: Relevance
“…In another study, Atmaca et al ( Atmaca et al, 2020 ) disclosed significant cytotoxicity of compound 292 against breast cancer (MCF-7), prostate cancer (DU-145), and lung cancer (H69AR) with IC50 values of 17.8 ± 0.24, 10.2 ± 1.4 and 49.9 ± 0.22 μg/ml, respectively, compared to 5-Fluorouracil. Compounds 293–294 showed stronger anticancer property against HepG2 (IC 50 : 26.62 and 20.29, respectively) and DLD-1 cells (IC 50 : 21.29 and 19.23 µM, respectively) than cisplatin (IC 50 : 30.38 and 60.79 µM) ( Caymaz et al, 2020 ). Particularly, compound 295–296 demonstrated potent anti-breast cancer effect by obstructing MCF-7 cell growth compared to standard cisplatin (IC 50 : 0.016 ± 0.001 and 0.018 ± 0.001 vs. 0.020 ± 0.009 µM).…”
Section: Biological Activitiesmentioning
confidence: 99%
“…In another study, Atmaca et al ( Atmaca et al, 2020 ) disclosed significant cytotoxicity of compound 292 against breast cancer (MCF-7), prostate cancer (DU-145), and lung cancer (H69AR) with IC50 values of 17.8 ± 0.24, 10.2 ± 1.4 and 49.9 ± 0.22 μg/ml, respectively, compared to 5-Fluorouracil. Compounds 293–294 showed stronger anticancer property against HepG2 (IC 50 : 26.62 and 20.29, respectively) and DLD-1 cells (IC 50 : 21.29 and 19.23 µM, respectively) than cisplatin (IC 50 : 30.38 and 60.79 µM) ( Caymaz et al, 2020 ). Particularly, compound 295–296 demonstrated potent anti-breast cancer effect by obstructing MCF-7 cell growth compared to standard cisplatin (IC 50 : 0.016 ± 0.001 and 0.018 ± 0.001 vs. 0.020 ± 0.009 µM).…”
Section: Biological Activitiesmentioning
confidence: 99%
“…As described in the experimental section (supplementary material), the MTT test was performed against four cancer cell lines specifically MCF-7, Caco-2, MDA231, T47D, [17,18] and one normal cell line, namely skin Fibroblasts (PCS201012). [19,20] which was selected as a reference of normal cells to evaluate the safety of our products as reported in table 1.…”
Section: Mtt Assaymentioning
confidence: 99%
“…[17] Benzimidazole derivatives have been reported for anticancer efficacy, [18] potential antitumor activity, [19] antiinflammatory activity, [20] anticonvulsant activity. [21] The phthalimide derivatives have been reported for anticancer activity, [22] anti-inflammatory, [23] antiproliferative, [24] in vitro anti antibacterial activity. [25]…”
Section: Introductionmentioning
confidence: 99%